AHA today urged the Occupational Safety and Health Administration to withdraw its Emergency Temporary Standard for occupational exposure to COVID-19, or at least allow the interim final rule to expire rather than issue a final rule. 

“Considering hospitals’ and health systems’ long-standing commitment to adhering to the [Centers for Disease Control and Prevention’s] science-based guidance and recommendations and the strong movement towards vaccinating all health care workers, we do not believe that the ETS is necessary,” AHA said in comments submitted to the agency on the interim final rule. 

If OSHA declines to withdraw the ETS, AHA strongly urged the agency to delay the ETS compliance dates for at least six months and address discrepancies between the ETS requirements and CDC guidelines, among other recommendations.

“Hospitals and health systems are struggling under the weight of the COVID-19 pandemic’s fourth wave and have told us that although they remain committed to following the CDC’s guidance, they need more time to fully implement the ETS’ many new requirements,” AHA said. 
 

Headline
The House Budget Committee July 16 passed a budget resolution by a 20-14 vote along party lines during a markup, paving the way for a new reconciliation bill…
Headline
The AHA July 13 commented on proposals by the Office of Management and Budget and other federal agencies to revise the Uniform Grants Regulation governing…
Headline
AHA Board Chair Marc Boom, M.D., took the stage July 13 to introduce AHA award winners and a town hall discussion on navigating the 2026 political…
Perspective
Public
As we move into the second half of 2026 and Congress returns to work in Washington, D.C., next week, lawmakers face a list of difficult issues that demand…
Headline
The AHA provided a statement June 30 to the House Ways and Means Committee in advance of a markup July 1 where the committee will consider legislation that…
Headline
The House Energy and Commerce Subcommittee on Health June 25 held a markup session on bills regarding healthcare price transparency, illicit drugs …